257 related articles for article (PubMed ID: 17075229)
1. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
Gu M; Wilton R; Stevens FJ
Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin synthesis in primary and myeloma amyloidosis.
Preud'homme JL; Ganeval D; Grünfeld JP; Striker L; Brouet JC
Clin Exp Immunol; 1988 Sep; 73(3):389-94. PubMed ID: 3145161
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
4. The V kappa III subgroup light chain proteins in AL amyloidosis & autoimmune diseases.
Alim MA; Hara Y; Kaji H; Shinoda T
Indian J Med Res; 2001 Jul; 114():30-5. PubMed ID: 11762204
[TBL] [Abstract][Full Text] [Related]
5. [A case of amyloidosis complicated by IgU/lambda/-myeloma multiplex].
Husz S; Török L; Kovács L; Szabó E; Simon N
Z Hautkr; 1979 Jul; 54(13):585-9. PubMed ID: 113946
[TBL] [Abstract][Full Text] [Related]
6. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
[TBL] [Abstract][Full Text] [Related]
7. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
[TBL] [Abstract][Full Text] [Related]
8. [Light chain myeloma or the pitfalls of myeloma diagnosis].
Zufferey P; Pugin P; Regamey C
Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
[TBL] [Abstract][Full Text] [Related]
9. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
10. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
[TBL] [Abstract][Full Text] [Related]
11. The amyloidosis of juvenile rheumatoid arthritis - comparative studies in Polish and American children II. Serum immunoglobulins, kappa and lambda light chain and C3 levels.
Filipowicz-Sosnowska AM; Baum J
J Rheumatol; 1979; 6(3):277-85. PubMed ID: 114636
[TBL] [Abstract][Full Text] [Related]
12. [A very unusual case of amyloidosis].
Jouvin MH; Nochy D; Bruneval P; Guettier C; Druet P; Bariéty J
Nephrologie; 1985; 6(3):159-62. PubMed ID: 3935940
[TBL] [Abstract][Full Text] [Related]
13. AL-amyloidosis is underdiagnosed in renal biopsies.
Novak L; Cook WJ; Herrera GA; Sanders PW
Nephrol Dial Transplant; 2004 Dec; 19(12):3050-3. PubMed ID: 15507480
[TBL] [Abstract][Full Text] [Related]
14. Analysis of V kappa I and V lambda II light chain genes in the expressed B-cell repertoire.
Manheimer-Lory A; Irigoyen M; Gaynor B; Monhian R; Splaver A; Diamond B
Ann N Y Acad Sci; 1995 Sep; 764():301-11. PubMed ID: 7486540
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
16. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
17. Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome.
El Hamel C; Thierry A; Trouillas P; Bridoux F; Carrion C; Quellard N; Goujon JM; Aldigier JC; Gombert JM; Cogné M; Touchard G
Nephrol Dial Transplant; 2010 Sep; 25(9):2982-90. PubMed ID: 20356978
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal rheumatoid factor (IgG lambda) its association with amyloid deposits containing lambda light chains.
Singh G; Myerowitz RL; Chervenick PA; Kelly RH
Arch Pathol Lab Med; 1981 Nov; 105(11):586-9. PubMed ID: 6794541
[TBL] [Abstract][Full Text] [Related]
20. Amino acid sequence diversity in mouse lambda 2 variable regions.
Elliott BW; Eisen HN; Steiner LA
J Immunol; 1984 Nov; 133(5):2757-61. PubMed ID: 6434637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
